from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1200/-

LFCtreatmentdescriptionclass of inhibitor

-1.607

Amikacinug/mL Amikacintranslation

-1.477

Cap5-10ug/mL Capreomycintranslation

-1.689

Rox10-50 ug/mL Roxithromycintranslation

-1.101

SM2-5 ug/mL Streptomycintranslation

-1.908

Tet5-10 ug/mL Tetracyclinetranslation

0.446

Rif0.2-5ug/mL Rifampicintranscription

0.636

Rifp0.1-0.5ug/mL Rifapentinetranscription

4.041

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.804

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.168

CPZ10-50 ug/mL Chlorpromazinerespiration

0.290

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.251

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.027

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.967

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.084

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.088

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.775

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.355

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.126

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.844

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.207

KCN5-20 ug/mL Potassium cyaniderespiration

-0.367

NaN30.2-2 mM Sodium aziderespiration

0.270

Nigericin50 uM Nigericinrespiration

-0.073

TRC10-150 ug/mL Triclosanrespiration

-1.201

TRZ10-25 ug/mL Thioridazinerespiration

-1.166

Valinomycin0.5-10 uM Valinomycinrespiration

0.776

ZnSO42 mM ZnSO4respiration

-0.620

menadione6-10 ug/mL Menadionerespiration

0.824

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.034

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.011

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.200

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.648

NRP_1Non-replicating persistence stage 1dosRassociated

0.205

Amp0.2mg/mL AmpicillincellWall

-0.052

Cephalexin20-100 ug/mL CephalexincellWall

-0.946

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.095

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.060

EMB10-20 ug/mL EthambutolcellWall

0.109

Eta12-40 ug/mL EthionamidecellWall

0.147

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.277

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.545

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.101

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.040

BZA0.12 mg/mL BenzamidearomaticAmides

0.052

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.308

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.133

H2O24 mM hydrogen peroxideDNAdamaging

-0.058

Levo10 ug/mL LevofloxacinDNAdamaging

0.025

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.841

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.383

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.087

UVUV-irradiationDNAdamaging

-0.674

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.131

Antimycin12.5-50 ug/mL Antimycin A?

-0.038

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.283

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.337

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.575

PA8240.2-2 ug/mL PA-824?

0.059

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.160

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.734

Verapamil50 uM Verapamil?

-0.249

mercaptoethanol2 mM 2-Mercaptoethanol?

0.302

methoxatin10-20 ug/mL Methoxatin?